Best Healthcare Companies in Jiangsu, China
The 137 best Healthcare companies in Jiangsu, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ausco Biopharma.
Ranked: Best Healthcare companies in Jiangsu
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ausco Biopharma Developer of recombinant proteins | $407M | 53 mo ago | — | 2017 | Shun Luo Founder & CEO | — | — | — |
| 2 | Novast Laboratories Researches and develops finished products and API formulations | $186M | 73 mo ago | — | 2005 | Prasad Pinnamaraju President | — | 7 patents Advanced solid dosage forms and nitrosamine impurity detection for pharmaceutical products | — |
| 3 | Virtue Diagnostics Provider of an in vitro assay platform for diagnostic solutions | $130M | 53 mo ago | 500 | 2019 | Johnson Zhang CEO | — | — | 1 job opening |
| 4 | Jiangsu Vcare Pharmatech CDMO manufacturing APIs | $107M | 29 mo ago | 500 | 2010 | — | — | 66 patents Small‑molecule kinase and receptor modulators for inflammatory and oncologic therapies | — |
| 5 | BrightGene Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and veterinary drugs | $80M | 3 mo ago | 559 | 2001 | — | — | — | — |
| 6 | Porton Advanced Solutions Provider of cell & gene therapy, discovery research, analytical development, and testing services | $80M | 46 mo ago | — | 2018 | Yangzhou Wang CEO | WordPressMySQLPHP+18 | — | 1 launch |
| 7 | IntellectiveBio CDMO focused on biopharmaceutical process development | $74M | 46 mo ago | 100 | 2018 | — | — | — | — |
| 8 | Qyuns Therapeutics Provider of drug development services to biopharma sector | $66M | 61 mo ago | 313 | 2015 | Jiwan Qui CEO | — | 76 patents Therapeutic monoclonal antibodies against IL‑33, IL‑36R, CD117, and TSLP for inflammatory diseases | — |
| 9 | Suzhou Ze Jing Biological Pharmaceutical Company developing small molecules & eukaryotic cell based recombinant protein drugs | $62M | 101 mo ago | 843 | 2009 | — | — | — | — |
| 10 | Alphamab Developer of antibody and protein-based biopharmaceuticals | $60M | 84 mo ago | 437 | 2009 | Ting Xu Founder | — | — | — |
| 11 | Maijie Translational Medicine Research Developer of diagnostic products | $51M | 68 mo ago | — | 2013 | Nick Zhang CEO | — | — | — |
| 12 | ACCRO R&D company focused on manufacturing of drugs for multiple therapeutic areas | $50M | 53 mo ago | — | 2017 | Sudan He Co-Founder | — | — | — |
| 13 | Suzhou Kaituo Pharmaceutical Company developing drugs for cancer, arthritis & CVS diseases | $44M | 101 mo ago | 290 | 2009 | Tong Youzhi CEO & President | Animate.cssBootstrapNginx+9 | — | — |
| 14 | Jiangsu Dongxing Wisdom Medical Technology Diversified medical device distributor | $38M | 68 mo ago | 697 | 2001 | — | — | — | — |
| 15 | Crystal Pharmatech Provider of solid state research services for small molecules | $24M | 89 mo ago | 17 | 2010 | Alex Chen Co-Founder | SalesforcePHPGSAP+20 | 234 patents Design and production of novel crystalline polymorphs of pharmaceutical active ingredients. | — |
| 16 | Eaglenos Manufacturer of diagnostic test kits | $21M | 36 mo ago | 220 | 2017 | — | WordPress Block EditorWordPressMySQL+13 | — | 2 launchs |
| 17 | Regend Therapeutics CDMO focused on manufacturing of cell & gene therapy services | $16M | 4 mo ago | — | 2015 | Jimmy Ruisheng Co-Founder | — | 10 patents Autologous cell‑based regenerative therapies for pulmonary fibrosis and kidney regeneration | — |
| 18 | Tianti Biotherapeutics Provider of drug research and development services for pharmaceutical sector | $16M | 54 mo ago | — | — | — | — | — | — |
| 19 | Suzhou Panomik Biomedical Technology CRO focused on providing data analysis services | $15M | 61 mo ago | — | 2013 | Ren Jianhong CEO & President | — | — | — |
| 20 | Lansion Biotechnology Provider of microfluidics-based in vitro diagnostic reagents and instruments | $14M | 45 mo ago | — | 2016 | Jeffery Chen Co-founder | — | 101 patents Patents concentrated in transport & manufacturing processes | — |
| 21 | Yiyuan Provider of R&D, production, sales, technical, and consultation services for medical X-ray tubes | $14M | 4 mo ago | 80 | 2018 | — | — | 11 patents Patents concentrated in computing, sensing & instrumentation | — |
| 22 | HOB IVD products for clinical immune diagnosis | $14M | 31 mo ago | 488 | 2007 | — | — | — | — |
| 23 | Jiangsu Huatai Chenguang Pharmaceutical Developer and manufacturer of APIs as well as finished dosage forms | $9M | 69 mo ago | 100 | 2009 | — | — | — | — |
| 24 | Nanjing F&S Pharmatech Manufacturer of APIs and pharmaceutical intermediates | $7M | 75 mo ago | — | 2015 | Yuan Fang Founder & Chairman | — | — | — |
| 25 | Puguang Biotechnology Developer and manufacturer of in-vitro diagnostic instruments and reagents for medical and veterinary use | $6M | 57 mo ago | 100 | 2017 | — | — | — | — |
| 26 | Bigway Medical Supplier of medical devices | $4M | 25 mo ago | — | — | — | — | — | — |
Top 12 Healthcare companies in Jiangsu
#1
Series C · Suzhou, Jiangsu · founded 2001 · 559 employees$80Mraised▾
Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and veterinary drugs. The company develops and produces a range of pharmaceutical products, including formulations for human use and active pharmaceutical ingredients. It also offers products related to veterinary medicine. A robust research and development system supports innovation and quality control throughout the production process. The company maintains comprehensive production and quality systems.
- Mar 2026Series C—
- Jan 2019Series C$80M
#2
Series C · Suzhou, Jiangsu · founded 2015$15.8Mraised▾
Developer of stem cell therapy products and human organ regenerative medicine. The company is mainly engaged in research and development of regenerative medicine, providing users with interstitial lung disease, assisted reproduction, stem cell storage and chronic obstructive pulmonary disease treatment solutions.
- Feb 2026Series C$50.6M
- Mar 2022Series B$15.8M
#3
Series B · Suzhou, Jiangsu · founded 2018 · 80 employees$13.8Mraised▾
Provider of R&D, production, sales, technical, and consultation services for medical X-ray tubes
- Jan 2026Series A$14.4M
- Jul 2023Series B$13.8M
- Sep 2021Seed—
#4
Series C · Nanjing, Jiangsu · founded 2010 · 500 employees$107.3Mraised▾
CDMO manufacturing APIs
- Jan 2024Series C$63.3M
- Dec 2022Series B$28.6M
- Jul 2021Series B$15.5M
#5
Series D · Nantong, Jiangsu · founded 2017$406.7Mraised▾
Ausco Biopharma develops recombinant proteins. They offer services including process development and production for recombinant protein products such as antibodies and antibody fragments, clotting factor products, and vaccine products such as viral vaccines and bacterial vaccines, viral particle products.
- Jan 2022Series D$235.9M
- Mar 2021Series C$61.4M
- Jul 2020Series B$64.3M
- Jan 2019Series A$45M
#6
Series B · Suzhou, Jiangsu · founded 2019 · 500 employees$130Mraised▾
Provider of an in vitro assay platform for diagnostic solutions. The company's technology can be used for early screening, diagnosis, treatment/monitoring and management of the minimal residual disease. The technology can be used in a variety of diseases such as infectious disease, cancer, maternal and fetal health, and chronic disease.
- Jan 2022Series B$100M
- Dec 2020Series A$30M
#7
Series B · Suzhou, Jiangsu · founded 2018$80Mraised▾
Provider of cell & gene therapy, discovery research, analytical development, and testing services
- Aug 2022Series B$80M
#8
Series C · Suzhou, Jiangsu · founded 2018 · 100 employees$74Mraised▾
Researcher and developer of biological and pharmaceutical solutions. The company, as a contract development and manufacturing organization (CDMO), is equipped with professional technology platforms such as protein science, cell engineering, cell culture, protein purification, analytical science, formulation development, preparation technology, as well as pilot plant, GMP workshop, aseptic preparation filling line, preparation freeze-drying production line and so on, providing clients with one-stop biopharmaceutical development and production services.
- Aug 2022Series C$74M
- Dec 2020Series A—
#9
Series E · Nantong, Jiangsu · founded 2005$186.3Mraised▾
Novast Laboratories, a subsidiary of Novast Holdings focuses on the design and development of finished products and API formulations for the worldwide markets and offers contract development and manufacturing services for both generic and innovator companies. It is an US FDA-inspected generic and speciality pharmaceutical company with business units based in the United States and China. It has signed a development and supply agreement with Eli Lilly and company in 2012 to jointly develop and commercialize several branded products in the China market.Their product portfolio includes oral contraceptives, hormonal drug products and other conventional dosage forms, including high containment oncology dosage forms (HPAPIs).
- May 2020Series E$141.3M
- Jun 2012Series C$20M
- Jul 2009Series C$25M
#10
Public · Suzhou, Jiangsu · founded 2007 · 488 employees$13.7Mraised▾
IVD products for clinical immune diagnosis
- Nov 2023Post IPO$13.7M
#11
Series A · Nanjing, Jiangsu · founded 2017 · 220 employees$21.2Mraised▾
Manufacturer of diagnostic test kits
- May 2023Series A$21.2M
#12
Series A · Xuzhou, Jiangsu$4.1Mraised▾
Supplier of medical devices
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.